The Food Safety and Standards Authority of India (FSSAI) on April 27, 2023, published the Draft Food Safety and Standards (Prohibition and Restrictions on Sales) Amendment Regulations, 2023 to further amend the Food Safety and Standards (Prohibition and Restrictions on Sales) Regulations, 2011
These Regulations shall come into force on the date of their publication in the official Gazette
The following has been amended namely: -
• In Regulation 2.1 which states “Sale of certain admixtures prohibited” in sub-regulation (2.1.1), for the 5th proviso starting with the words ‘Provided also that prohibition in Regulation 2.1.1’ and ending with words ‘the relevant standard prescribed by these regulations.’, the following shall be substituted, namely: -
“Provided also that prohibition in Regulation 2.1.1 (5) shall remain inoperative in respect of Multisource Edible Oil specified under the clause (24) of sub-regulation (2.2.1) of regulation ‘2.2 of Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011, and Multisource Edible Oil shall not be sold in a package weighing more than 15 liters.”
• In Regulation 2.3 which states “Prohibition and Restriction on sale of certain products” the sub-regulation 2.3.8 shall be omitted.
• In sub-regulation 2.3.14 of regulation 2.3 the following clauses shall be omitted namely: -
(a) clause (4) and (5) shall be omitted.
(b) in clause (11), the words “AGMARK certification mark bearing” shall be omitted.
(c) in clause (13), the words “AGMARK Certification mark bearing” shall be omitted.
(d) clauses (17) and (18) shall be omitted.
• The Form A which specifies “Declaration” shall be omitted.
Objections or suggestions which may be received with respect to the said draft regulations within the period of 60 days from the publication of this notification in the official gazette shall be considered by the Food Safety and Standards Authority of India.
Objections or suggestions, if any, may be addressed to the Chief Executive Officer, Food Safety and Standards Authority of India, FDA Bhawan, Kotla Road, New Delhi- 110002, or sent via email at [email protected].
[Notification No. F. No. REG-11027/2/2022-Regulation-FSSAI]
